EUR J CANCER 润色咨询

EUROPEAN JOURNAL OF CANCER

出版年份：1990 年文章数：4798 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：4.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2026-04-03 ms5000001624598379 来自四川省

    这个期刊不热门啊 最近都没人讨论

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2022-12-11 ms3000001872426513 来自河南省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤免疫
    经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2026-01-19 ms9000000157177317 来自浙江省

    投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2024-09-12 ms9000000770995662 来自天津

    偏重的研究方向：肿瘤免疫
    经验分享：with editor已经一周了，还是没有变化，这是正常的吗？

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2023-07-28 ms7000000964395486 来自浙江省

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向：肿瘤
    经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-30 ms5000002013297398

    要求字数2500？怎么感觉发的文章都超过2500了？

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2024-04-17 ms5000000719501821 来自上海

    做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2024-08-28 1ddebd51m79(暂无匿称) 来自浙江省

    无

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2024-08-27 1ddebd51m79(暂无匿称) 来自浙江省

    无

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2306111, encodeId=9137230611139, content=这个期刊不热门啊 最近都没人讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62eb9744494, createdName=ms5000001624598379, createdTime=Fri Apr 03 00:12:26 CST 2026, time=2026-04-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2297691, encodeId=0f66229e69189, content=投稿后直接显示Under review 一周了是什么原因，这个是还没送审吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da128690012, createdName=ms9000000157177317, createdTime=Mon Jan 19 09:02:19 CST 2026, time=2026-01-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫<br>经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1065351, encodeId=fdc41065351ed, content=要求字数2500？怎么感觉发的文章都超过2500了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e35596459, createdName=ms5000002013297398, createdTime=Sat Oct 30 21:31:03 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗 ，跪求 着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted<br>9-26 with editor<br>9-29 decision in process<br>10-5 reject<br>和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 YJJJJJ

    9-23 submittted
    9-26 with editor
    9-29 decision in process
    10-5 reject
    和很多人说的一样，decision in process状态持续的很久。

    1

    展开1条回复
共178条页码: 1/18页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分